Senseonics Holdings, Inc. (SENS): Price and Financial Metrics


Senseonics Holdings, Inc. (SENS): $1.32

0.04 (+3.13%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

SENS POWR Grades

  • SENS scores best on the Quality dimension, with a Quality rank ahead of 57.99% of US stocks.
  • The strongest trend for SENS is in Growth, which has been heading down over the past 179 days.
  • SENS ranks lowest in Growth; there it ranks in the 2nd percentile.

SENS Stock Summary

  • With a price/earnings ratio of 2.25, SENSEONICS HOLDINGS INC P/E ratio is greater than that of about just 2.68% of stocks in our set with positive earnings.
  • With a price/sales ratio of 52.19, SENSEONICS HOLDINGS INC has a higher such ratio than 96.47% of stocks in our set.
  • SENS's equity multiplier -- a measure of assets relative to shareholders'equity -- is greater than that of only 4.53% of US stocks.
  • If you're looking for stocks that are quantitatively similar to SENSEONICS HOLDINGS INC, a group of peers worth examining would be VECO, INVA, NVMI, AMPH, and ALRM.
  • Visit SENS's SEC page to see the company's official filings. To visit the company's web site, go to www.senseonics.com.

SENS Valuation Summary

  • SENS's price/sales ratio is 44.7; this is 2252.63% higher than that of the median Healthcare stock.
  • Over the past 82 months, SENS's EV/EBIT ratio has gone up 10.7.

Below are key valuation metrics over time for SENS.

Stock Date P/S P/B P/E EV/EBIT
SENS 2022-09-23 44.7 38.5 1.9 1.9
SENS 2022-09-22 43.4 37.4 1.9 1.8
SENS 2022-09-21 45.8 39.4 2.0 1.9
SENS 2022-09-20 48.1 41.5 2.1 2.0
SENS 2022-09-19 50.2 43.2 2.2 2.1
SENS 2022-09-16 52.2 45.0 2.3 2.2

SENS's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • SENS has a Quality Grade of D, ranking ahead of 13.13% of graded US stocks.
  • SENS's asset turnover comes in at 0.084 -- ranking 71st of 76 Measuring and Control Equipment stocks.
  • A, ASTC, and MTD are the stocks whose asset turnover ratios are most correlated with SENS.

The table below shows SENS's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 0.084 0.401 -5.465
2021-03-31 0.098 0.360 -5.709
2020-12-31 0.127 -3.509 -2.449
2020-09-30 0.158 -2.814 -1.660
2020-06-30 0.144 -2.385 -1.365
2020-03-31 0.165 -1.997 -1.885

SENS Stock Price Chart Interactive Chart >

Price chart for SENS

SENS Price/Volume Stats

Current price $1.32 52-week high $4.28
Prev. close $1.28 52-week low $0.77
Day low $1.26 Volume 4,230,300
Day high $1.34 Avg. volume 7,790,794
50-day MA $1.62 Dividend yield N/A
200-day MA $1.81 Market Cap 614.39M

Senseonics Holdings, Inc. (SENS) Company Bio


Senseonics Holdings, Inc. focuses on the design, development, and commercialization of glucose monitoring systems for people with diabetes. The company was founded in 1996 and is based in Germantown, Maryland.


SENS Latest News Stream


Event/Time News Detail
Loading, please wait...

SENS Latest Social Stream


Loading social stream, please wait...

View Full SENS Social Stream

Latest SENS News From Around the Web

Below are the latest news stories about SENSEONICS HOLDINGS INC that investors may wish to consider to help them evaluate SENS as an investment opportunity.

Cigna's (CI) Arm Adds Five Digital Health Apps to Its Platform

Cigna's (CI) unit bolsters its clinical platform Digital Health Formulary by including five on-line solutions, aiming to relieve people from chronic medical conditions.

Yahoo | September 16, 2022

Senseonics to Participate in the Morgan Stanley 20th Annual Global Healthcare Conference

GERMANTOWN, Md., September 07, 2022--Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today announced plans to participate in the upcoming Morgan Stanley Global Healthcare Conference in New York, NY.

Yahoo | September 7, 2022

Humana (HUM) Brings Home Health Unit of KAH Under CenterWell

Humana (HUM) wraps up rebranding KAH's home health operations to the CenterWell brand. This leads to the clubbing of HUM's three payer-agnostic care services into a common suite.

Yahoo | September 5, 2022

Senseonics Announces CFO Transition

GERMANTOWN, Md., September 01, 2022--Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today announced its Chief Financial Officer, Nick Tressler, is transitioning from his position, effective September 1, 2022. Rick Sullivan, Senseonics' current Vice President of Finance, has been appointed to succeed Mr. Tressler as Chief Finan

Yahoo | September 1, 2022

Senseonics to Present at the Inaugural Gilmartin Group Emerging Growth Company Showcase

GERMANTOWN, Md., August 17, 2022--Senseonics Holdings, Inc. (NYSE American: SENS) a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today announced plans to present at the upcoming Inaugural Gilmartin Group Emerging Showcase, taking place virtually. Management is scheduled to present on Wednesday, August 31, 2022 at 3:00pm ET.

Yahoo | August 17, 2022

Read More 'SENS' Stories Here

SENS Price Returns

1-mo -26.26%
3-mo 23.36%
6-mo -33.33%
1-year -63.03%
3-year 30.69%
5-year -55.85%
YTD -50.56%
2021 206.26%
2020 -4.83%
2019 -64.63%
2018 -2.63%
2017 -0.37%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.7015 seconds.